MedTrace Logo

The Archimedes Biodegradable Biliary and Pancreatic Stents

NCT03767166 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-03-18

No results posted yet for this study

Summary

This is a prospective, phase II, single-centre, non-randomised, single-arm study, enrolling patients with benign and malignant bilio-pancreatic diseases with an indication to biliary or pancreatic plastic stent positioning during ERCP.

On procedure day, the study team will confirm that the patient meets all the inclusion criteria and none of the exclusion criteria.

The patient will undergo the ABS insertion and monitored and follow-up accordingly to biodegration variant.

Conditions

Interventions

DEVICE

Biodegradable biliary and pancreatic stents placement

Biodegradable biliary and pancreatic stents placement

Sponsors & Collaborators

  • Istituto Clinico Humanitas

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03767166 on ClinicalTrials.gov